Related content

Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative

By Lampropoulos Christos   Hughes Graham   Cruz David  

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 981-983

Springer Publishing Company

Access to resources Recommend Favorite

Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis

By Danieli Maria   Moretti Romina   Gambini Simona   Paolini Luca   Gabrielli Armando  

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 531-536

Springer Publishing Company

Access to resources Recommend Favorite

Thromboembolic Complications of Intravenous Immunoglobulin Treatment

By  

European Neurology, Vol. 52, Iss. 3, 2004-11 ,pp. : 141-144

Karger

Access to resources Recommend Favorite

Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 167-168

Karger

Access to resources Recommend Favorite

High-dose intravenous immunoglobulin infusion in polyarteritis nodosa: Report on one case and review of the literature

By Asano Yoshihide   Ihn Hironobu   Maekawa Takeo   Kadono Takafumi   Tamaki Kunihiko  

Clinical Rheumatology, Vol. 25, Iss. 3, 2006-05 ,pp. : 396-398

Springer Publishing Company

Access to resources Recommend Favorite